Chemotherapy and Hormone Therapy in Gynecologic Cancer
AbstractSignificant palliation can be obtained in some patients with ovarian or uterine cancer using drug therapy, and should be tried when other modalities have failed. Gestational trophoblastic disease is curable with drugs, but requires skillful evaluation and management. The use of combination chemotherapy in cervical cancer and other advanced gynecologic cancers should be evaluated further. Chemotherapy as an adjunct to early treatment requires careful evaluation in controlled trials, and ultimately may improve the outlook for these patients.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($15)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.